Abstract
Skeletal dysplasias are a group of disorders with a disturbance in development and/or growth of cartilage and/or bone. Epiphysis, metaphysis, and diaphysis of long bones are affected in a generalized manner with or without involvement of membranous bone of the skull. A dysostosis affects one or some skeletal elements, while the other bones remain normal. There are approximately 450 different disorders known with involvement of the skeleton. Some 50 dysplasias are lethal. Lethality is usually based on thoracic underdevelopment and lung hypoplasia. The overall frequency among stillbirths and liveborns has been estimated to be 1 per 4000 to 1 per 6000 births and the frequency among perinatal deaths to be 1 per 110 deaths.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rasmussen SA, Bieber FR, Benacerraf BR, Lachman RS, Rimoin DL, Holmes LB. Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis. Am J Med Genet. 1996;61:49–58.
Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet. 1986;23:328–32.
Kallen B, Knudsen LB, Mutchinick O, et al. Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries: an international feasibility study. Int J Epidemiol. 1993;22:107–15.
Camera G, Mastroacovo P. Birth prevalence of skeletal dysplasias in the Italian multicentric monitoring system for birth defects. In: Papadatos CJ, Bartsocas CS, editors. Skeletal dysplasias. New York: Allen R Liss; 1982. p. 441–9.
Hall BD. Approach to skeletal dysplasia. Pediatr Clin N Am. 1992;39:279–305.
Winter RM, Sandin BM, Mitchell RA, Price AB. The radiology of stillbirths and neonatal deaths. Br J Obstet Gynaecol. 1984;91:762–5.
van der Harten HJ, Brons JT, Schipper NW, Dijkstra PF, Meijer CJ, van Geijn HP. The prenatal development of the normal human skeleton: a combined ultrasonographic and post-mortem radiographic study. Pediatr Radiol. 1990;21:52–6.
Alanay Y, Lachman RS. A review of the principles of radiological assessment of skeletal dysplasias. J Clin Res Pediatr Endocrinol. 2011;3:163–78.
Cremin B, Beighton P. Bone dysplasias of infancy, a radiological atlas. Berlin: Springer; 1978.
Kozlowski K. The radiographic clues in the diagnosis of bone dysplasias. Pediatr Radiol. 1985;15:1–3.
Lachman RS. Fetal imaging in the skeletal dysplasias: overview and experience. Pediatr Radiol. 1994;24:413–7.
Meyer DB, O’Rahilly R. Roentgenographic investigation of the human skeleton during early fetal life. Am J Roentgenol Radium Ther Nucl Med. 1956;76:455–68.
van Zalen-Sprock RM, Brons JT, van Vugt JM, van der Harten HJ, van Geijn HP. Ultrasonographic and radiologic visualization of the developing embryonic skeleton. Ultrasound Obstet Gynecol. 1997;9:392–7.
Gilbert EF, Yang SS, Langer L, Opitz JM, Roskamp JO, Heidelberger KP. Pathologic changes of osteochondrodysplasia in infancy. A review. Pathol Annu. 1987;22:283–345.
Nikkels PGJ. Diagnostic approach to congenital osteochondrodysplasias at autopsy. Diagn Histopathol. 2009;15:413–24.
Sillence DO, Horton WA, Rimoin DL. Morphologic studies in the skeletal dysplasias. Am J Pathol. 1979;96:813–70.
Spranger J. International classification of osteochondrodysplasias. The International Working Group on Constitutional Diseases of Bone. Eur J Pediatr. 1992;151:407–15.
Spranger J. Bone dysplasia ‘families’. Pathol Immunopathol Res. 1988;7:76–80.
International nomenclature and classification of the osteochondrodysplasias (1997). International Working Group on Constitutional Diseases of Bone. Am J Med Genet. 1998;79:376–82.
Hall CM. International nosology and classification of constitutional disorders of bone (2001). Am J Med Genet. 2002;113:65–77.
Horton WA. Evolution of the bone dysplasia family. Am J Med Genet. 1996;63:4–6.
Superti-Furga A, Unger S. Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A. 2007;143:1–18.
Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A. 2011;155A:943–68.
Kornak U, Mundlos S. Genetic disorders of the skeleton: a developmental approach. Am J Hum Genet. 2003;73:447–74.
Karaplis AC, Luz A, Glowacki J, et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 1994;8:277–89.
Den Hollander NS, van der Harten HJ, Vermeij-Keers C, Niermeijer MF, Wladimiroff JW. First-trimester diagnosis of Blomstrand lethal osteochondrodysplasia. Am J Med Genet. 1997;73:345–50.
Oostra RJ, van der Harten JJ, Rijnders WP, Scott RJ, Young MP, Trump D. Blomstrand osteochondrodysplasia: three novel cases and histological evidence for heterogeneity. Virchows Arch. 2000;436:28–35.
Jobert AS, Zhang P, Couvineau A, et al. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest. 1998;102:34–40.
Karperien M, van der Harten HJ, van Schooten R, et al. A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia. J Clin Endocrinol Metab. 1999;84:3713–20.
Weisman PS, Kashireddy PV, Ernst LM. Pathologic diagnosis of achondrogenesis type 2 in a fragmented fetus: case report and evidence-based differential diagnostic approach in the early midtrimester. Pediatr Dev Pathol. 2014;17:10–20.
Brons JT, van der Harten JJ, van Geijn HP, et al. Ratios between growth parameters for the prenatal ultrasonographic diagnosis of skeletal dysplasias. Eur J Obstet Gynecol Reprod Biol. 1990;34:37–46.
Romero R, Athanassiadis AP, Jeanty P. Fetal skeletal anomalies. Radiol Clin N Am. 1990;28:75–99.
Sharony R, Browne C, Lachman RS, Rimoin DL. Prenatal diagnosis of the skeletal dysplasias. Am J Obstet Gynecol. 1993;169:668–75.
Wladimiroff JW, Niermeijer MF, Laar J, Jahoda M, Stewart PA. Prenatal diagnosis of skeletal dysplasia by real-time ultrasound. Obstet Gynecol. 1984;63:360–4.
Spranger JW, Brill PW, Superti-Furga A, Unger S, Nishimura G. Bone dysplasias: an Atlas of genetic disorders of skeletal development. 3rd ed. Oxford University Press; New York, USA. 2012.
Lachman R. Taybi and Lachman’s radiology of syndromes, metabolic disorders and skeletal dysplasias. 5th ed. Elsevier; Philadelphia, USA. 2006.
Maroteaux P, Lamy M, Robert JM. Le nanisma thanatophore. Presse Med. 1967;75:2519–24.
Baker KM, Olson DS, Harding CO, Pauli RM. Long-term survival in typical thanatophoric dysplasia type 1. Am J Med Genet. 1997;70:427–36.
MacDonald IM, Hunter AG, MacLeod PM, MacMurray SB. Growth and development in thanatophoric dysplasia. Am J Med Genet. 1989;33:508–12.
Maroteaux P, Stanescu V, Stanescu R. The lethal chondrodysplasias. Clin Orthop Relat Res. 1976;114:31–45.
Ornoy A, Adomian GE, Eteson DJ, Burgeson RE, Rimoin DL. The role of mesenchyme-like tissue in the pathogenesis of thanatophoric dysplasia. Am J Med Genet. 1985;21:613–30.
Knisely AS, Ambler MW. Temporal-lobe abnormalities in thanatophoric dysplasia. Pediatr Neurosci. 1988;14:169–76.
Pistorius LR, Manten GT, Nikkels PG. Thanatophoric dysplasia: role of 3D sonography. AJR Am J Roentgenol. 2010;194:W539.
Wongmongkolrit T, Bush M, Roessmann U. Neuropathological findings in thanatophoric dysplasia. Arch Pathol Lab Med. 1983;107:132–5.
Holtermüller K, Wiedemann HR. Kleeblattschädel syndrome. Med Monatsschr. 1960;14:439–46.
Langer Jr LO, Yang SS, Hall JG, et al. Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet Suppl. 1987;3:167–79.
Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101–16.
Van Dijk FS, Cobben JM, Kariminejad A, et al. Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol. 2011;2:1–20.
Van Dijk FS, Pals G, van Rijn RR, Nikkels PG, Cobben JM. Classification of osteogenesis imperfecta revisited. Eur J Med Genet. 2010;53:1–5.
Marini JC, Blissett AR. New genes in bone development: what’s new in osteogenesis imperfecta. J Clin Endocrinol Metab. 2013;98:3095–103.
Cole WG. Advances in osteogenesis imperfecta. Clin Orthop Relat Res. 2002;401:6–16.
Brons JT, van der Harten HJ, Wladimiroff JW, et al. Prenatal ultrasonographic diagnosis of osteogenesis imperfecta. Am J Obstet Gynecol. 1988;159:176–81.
Cremin B, Goodman H, Spranger J, Beighton P. Wormian bones in osteogenesis imperfecta and other disorders. Skelet Radiol. 1982;8:35–8.
Van Dijk FS, Nikkels PG, Den Hollander NS, et al. Lethal/severe osteogenesis imperfecta in a large family: a novel homozygous LEPRE1 mutation and bone histological findings. Pediatr Dev Pathol. 2011;14:228–34.
van der Harten HJ, Brons JT, Dijkstra PF, et al. Perinatal lethal osteogenesis imperfecta: radiologic and pathologic evaluation of seven prenatally diagnosed cases. Pediatr Pathol. 1988;8:233–52.
Pace JM, Chitayat D, Atkinson M, Wilcox WR, Schwarze U, Byers PH. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases. J Med Genet. 2002;39:23–9.
Steiner RD, Pepin M, Byers PH. Studies of collagen synthesis and structure in the differentiation of child abuse from osteogenesis imperfecta. J Pediatr. 1996;128:542–7.
Caswell AM, Whyte MP, Russell RG. Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects. Crit Rev Clin Lab Sci. 1991;28:175–232.
Shohat M, Rimoin DL, Gruber HE, Lachman RS. Perinatal lethal hypophosphatasia; clinical, radiologic and morphologic findings. Pediatr Radiol. 1991;21:421–7.
Macfarlane JD, Kroon HM, van der Harten JJ. Phenotypically dissimilar hypophosphatasia in two sibships. Am J Med Genet. 1992;42:117–21.
Wladimiroff JW, Niermeijer MF, van der Harten JJ, et al. Early prenatal diagnosis of congenital hypophosphatasia: case report. Prenat Diagn. 1985;5:47–52.
Ornoy A, Adomian GE, Rimoin DL. Histologic and ultrastructural studies on the mineralization process in hypophosphatasia. Am J Med Genet. 1985;22:743–58.
Henthorn PS, Whyte MP. Infantile hypophosphatasia: successful prenatal assessment by testing for tissue-non-specific alkaline phosphatase isoenzyme gene mutations. Prenat Diagn. 1995;15:1001–6.
Orimo H, Nakajima E, Hayashi Z, et al. First-trimester prenatal molecular diagnosis of infantile hypophosphatasia in a Japanese family. Prenat Diagn. 1996;16:559–63.
Nishimura G, Nakashima E, Mabuchi A, et al. Identification of COL2A1 mutations in platyspondylic skeletal dysplasia, Torrance type. J Med Genet. 2004;41:75–9.
Zankl A, Neumann L, Ignatius J, et al. Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies. Am J Med Genet A. 2005;133A:61–7.
Borochowitz Z, Lachman R, Adomian GE, Spear G, Jones K, Rimoin DL. Achondrogenesis type I: delineation of further heterogeneity and identification of two distinct subgroups. J Pediatr. 1988;112:23–31.
Langer Jr LO, Spranger JW, Greinacher I, Herdman RC. Thanatophoric dwarfism. A condition confused with achondroplasia in the neonate, with brief comments on achondrogenesis and homozygous achondroplasia. Radiology. 1969;92:285–94.
Saldino RM. Lethal short-limbed dwarfism: achondrogenesis and thanatophoric dwarfism. Am J Roentgenol Radium Ther Nucl Med. 1971;112:185–97.
van der Harten HJ, Brons JT, Dijkstra PF, et al. Achondrogenesis-hypochondrogenesis: the spectrum of chondrogenesis imperfecta. A radiological, ultrasonographic, and histopathologic study of 23 cases. Pediatr Pathol. 1988;8:571–97.
Soothill PW, Vuthiwong C, Rees H. Achondrogenesis type 2 diagnosed by transvaginal ultrasound at 12 weeks’ gestation. Prenat Diagn. 1993;13:523–8.
Meizner I, Barnhard Y. Achondrogenesis type I diagnosed by transvaginal ultrasonography at 13 weeks’ gestation. Am J Obstet Gynecol. 1995;173:1620–2.
Smits P, Bolton AD, Funari V, et al. Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med. 2010;362:206–16.
Superti-Furga A, Hastbacka J, Wilcox WR, et al. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet. 1996;12:100–2.
Chen H, Liu CT, Yang SS. Achondrogenesis: a review with special consideration of achondrogenesis type II (Langer-Saldino). Am J Med Genet. 1981;10:379–94.
Gruber HE, Lachman RS, Rimoin DL. Quantitative histology of cartilage vascular canals in the human rib. Findings in normal neonates and children and in achondrogenesis II-hypochondrogenesis. J Anat. 1990;173:69–75.
Godfrey M, Keene DR, Blank E, et al. Type II achondrogenesis-hypochondrogenesis: morphologic and immunohistopathologic studies. Am J Hum Genet. 1988;43:894–903.
Spranger J, Winterpacht A, Zabel B. The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr. 1994;153:56–65.
Horton WA, Rimoin DL, Lachman RS, et al. The phenotypic variability of diastrophic dysplasia. J Pediatr. 1978;93:609–13.
Qureshi F, Jacques SM, Johnson SF, et al. Histopathology of fetal diastrophic dysplasia. Am J Med Genet. 1995;56:300–3.
Schrander-Stumpel C, Havenith M, Linden EV, Maertzdorf W, Offermans J, van der Harten HJ. De la Chapelle dysplasia (atelosteogenesis type II): case report and review of the literature [corrected]. Clin Dysmorphol. 1994;3:318–27.
Sillence D, Worthington S, Dixon J, Osborn R, Kozlowski K. Atelosteogenesis syndromes: a review, with comments on their pathogenesis. Pediatr Radiol. 1997;27:388–96.
Rossi A, van der Harten HJ, Beemer FA, et al. Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia. Hum Genet. 1996;98:657–61.
Ehlen HW, Buelens LA, Vortkamp A. Hedgehog signaling in skeletal development. Birth Defects Res C Embryo Today. 2006;78:267–79.
Huber C, Cormier-Daire V. Ciliary disorder of the skeleton. Am J Med Genet C Semin Med Genet. 2012;160C:165–74.
Elcioglu NH, Hall CM. Diagnostic dilemmas in the short rib-polydactyly syndrome group. Am J Med Genet. 2002;111:392–400.
Saldino RM, Noonan CD. Severe thoracic dystrophy with striking micromelia, abnormal osseous development, including the spine, and multiple visceral anomalies. Am J Roentgenol Radium Ther Nucl Med. 1972;114:257–63.
Verma IC, Bhargava S, Agarwal S. An autosomal recessive form of lethal chondrodystrophy with severe thoracic narrowing, rhizoacromelic type of micromelia, polydacytly and genital anomalies. Birth Defects Orig Artic Ser. 1975;11:167–74.
Naumoff P, Young LW, Mazer J, Amortegui AJ. Short rib-polydactyly syndrome type 3. Radiology. 1977;122:443–7.
Sillence D, Kozlowski K, Bar-ziv J, Fuhrumann-Rieger A, Fuhrmann W, Pascu F. Perinatally lethal short rib-polydactyly syndromes. 1. Variability in known syndromes. Pediatr Radiol. 1987;17:474–80.
Sillence DO. Non-Majewski short rib-polydactyly syndrome. Am J Med Genet. 1980;7:223–9.
Yang SS, Langer Jr LO, Cacciarelli A, et al. Three conditions in neonatal asphyxiating thoracic dysplasia (Jeune) and short rib-polydactyly syndrome spectrum: a clinicopathologic study. Am J Med Genet Suppl. 1987;3:191–207.
Bernstein R, Isdale J, Pinto M, Du Toit ZJ, Jenkins T. Short rib-polydactyly syndrome: a single or heterogeneous entity? A re-evaluation prompted by four new cases. J Med Genet. 1985;22:46–53.
Yang SS, Lin CS, Al SA, Nangia BS, Bernstein J. Short rib-polydactyly syndrome, type 3 with chondrocytic inclusions: report of a case and review of the literature. Am J Med Genet. 1980;7:205–13.
Majewski F, Pfeiffer RA, Lenz W, Muller R, Feil G, Seiler R. Polysyndactylie, verkürzte Gliedmassen und Geni- talfehlbindungen, Kenzeichen eines neuen Syndroms? Z Kinderheilk. 1971;111:118–38.
Chen H, Yang SS, Gonzalez E, Fowler M, Al SA. Short rib-polydactyly syndrome, Majewski type. Am J Med Genet. 1980;7:215–22.
Beemer FA, Langer Jr LO, Klep-de Pater JM, et al. A new short rib syndrome: report of two cases. Am J Med Genet. 1983;14:115–23.
Wessels MW, Den Hollander NJ, de Krijger RR, et al. Fetus with an unusual form of nonrhizomelic chondrodysplasia punctata: case report and review. Am J Med Genet A. 2003;120A:97–104.
Tompson SW, Faqeih EA, la-Kokko L, et al. Dominant and recessive forms of fibrochondrogenesis resulting from mutations at a second locus, COL11A2. Am J Med Genet A. 2012;158A:309–14.
Tompson SW, Bacino CA, Safina NP, et al. Fibrochondrogenesis results from mutations in the COL11A1 type XI collagen gene. Am J Hum Genet. 2010;87:708–12.
Lazzaroni-Fossati F, Stanescu V, Stanescu R, Serra G, Magliano P, Maroteaux P. La fibrochondrogenese. Arch Fr Pediatr. 1978;35:1096–104.
Bankier A, Fortune D, Duke J, Sillence DO. Fibrochondrogenesis in male twins at 24 weeks gestation. Am J Med Genet. 1991;38:95–8.
Roth M. Campomelic syndrome: experimental models and pathomechanism. Pediatr Radiol. 1991;21:220–5.
Thong MK, Scherer G, Kozlowski K, Haan E, Morris L. Acampomelic campomelic dysplasia with SOX9 mutation. Am J Med Genet. 2000;93:421–5.
Foster JW, Dominguez-Steglich MA, Guioli S, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature. 1994;372:525–30.
Wagner T, Wirth J, Meyer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell. 1994;79:1111–20.
Mansour S, Hall CM, Pembrey ME, Young ID. A clinical and genetic study of campomelic dysplasia. J Med Genet. 1995;32:415–20.
Alanay Y, Krakow D, Rimoin DL, Lachman RS. Angulated femurs and the skeletal dysplasias: experience of the international skeletal dysplasia registry (1988–2006). Am J Med Genet A. 2007;143A:1159–68.
Cormier-Daire V, Genevieve D, Munnich A, Le MM. New insights in congenital bowing of the femora. Clin Genet. 2004;66:169–76.
Camacho N, Krakow D, Johnykutty S, et al. Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia. Am J Med Genet A. 2010;152A:1169–77.
Unger S, Lausch E, Stanzial F, et al. Fetal akinesia in metatropic dysplasia: the combined phenotype of chondrodysplasia and neuropathy? Am J Med Genet A. 2011;155A:2860–4.
Wessels MW, Den Hollander NS, de Krijger RR, et al. Prenatal diagnosis of boomerang dysplasia. Am J Med Genet A. 2003;122A:148–54.
Bicknell LS, Morgan T, Bonafe L, et al. Mutations in FLNB cause boomerang dysplasia. J Med Genet. 2005;42:e43.
Hiraoka S, Furuichi T, Nishimura G, et al. Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human. Nat Med. 2007;13:1363–7.
Nikkels PG, Stigter RH, Knol IE, van der Harten HJ. Schneckenbecken dysplasia, radiology, and histology. Pediatr Radiol. 2001;31:27–30.
Oppenheimer SJ, Snodgrass GJ. Neonatal rickets. Histopathology and quantitative bone changes. Arch Dis Child. 1980;55:945–9.
Paakkonen M, Peltola H. Antibiotic treatment for acute haematogenous osteomyelitis of childhood: moving towards shorter courses and oral administration. Int J Antimicrob Agents. 2011;38:273–80.
Faden H, Grossi M. Acute osteomyelitis in children. Reassessment of etiologic agents and their clinical characteristics. Am J Dis Child. 1991;145:65–9.
Jacobs NM. Pneumococcal osteomyelitis and arthritis in children. A hospital series and literature review. Am J Dis Child. 1991;145:70–4.
Knudsen CJ, Hoffman EB. Neonatal osteomyelitis. J Bone Joint Surg (Br). 1990;72:846–51.
Fox L, Sprunt K. Neonatal osteomyelitis. Pediatrics. 1978;62:535–42.
Weissberg ED, Smith AL, Smith DH. Clinical features of neonatal osteomyelitis. Pediatrics. 1974;53:505–10.
Lim MO, Gresham EL, Franken Jr EA, Leake RD. Osteomyelitis as a complication of umbilical artery catheterization. Am J Dis Child. 1977;131:142–4.
Knudsen FU, Petersen S. Neonatal septic osteo-arthritis due to umbilical artery catheterisation. Acta Paediatr Scand. 1977;66:225–7.
Woods CR. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis. 2005;16:245–57.
Woods CR. Congenital syphilis-persisting pestilence. Pediatr Infect Dis J. 2009;28:536–7.
Toohey JS. Skeletal presentation of congenital syphilis: case report and review of the literature. J Pediatr Orthop. 1985;5:104–6.
Ikeda MK, Jenson HB. Evaluation and treatment of congenital syphilis. J Pediatr. 1990;117:843–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing
About this chapter
Cite this chapter
Nikkels, P.G.J. (2015). The Skeletal System. In: Khong, T.Y., Malcomson, R.D.G. (eds) Keeling’s Fetal and Neonatal Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-19207-9_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-19207-9_31
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19206-2
Online ISBN: 978-3-319-19207-9
eBook Packages: MedicineMedicine (R0)